Menu
Back to Journals » Journal of Pain Research » Volume 11
Risk of respiratory depression with opioids and concomitant gabapentinoids [Corrigendum]
Authors Savelloni J , Gunter H , Lee KC , Hsu C, Yi C, Edmonds KP , Furnish T, Atayee RS
Received 28 June 2018
Accepted for publication 28 June 2018
Published 17 September 2018 Volume 2018:11 Pages 1877—1878
Savelloni J, Gunter H, Lee KC, et al. J Pain Res. 2017;10: 2635–2641.
Page 2640, References, the references 13 and 14 are in the incorrect order and should read as shown below.
13. Keskinbora K, Pekel AF, Aydinli I. Gabapentin and an opioid combination
versus opioid alone for the management of neuropathic cancer pain:
a randomized open trial. J Pain Symptom Manage. 2007;34(2):183–189.
14. Meisenberg B, Ness J, Rao S, Rhule J, Ley C. Implementation of solutions
to reduce opioid-induced oversedation and respiratory depression.
Am J Health Syst Pharm. 2017;74(3):162–169.
© 2018 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.